Titelia

Holdings of GREAT POINT PARTNERS LLC

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
31 in 2 countries
Top ten
60.8 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1Apogee Therapeutics Inc 374,00031.5M $
2Vor BioPharma Inc 1,750,00031.2M $
3Amylyx Pharmaceuticals Inc 1,750,00024.3M $
4Nektar Therapeutics 316,45322.8M $
5Alumis Inc 856,06118.9M $
6Annexon Inc 2,500,00013.9M $
7KalVista Pharmaceuticals Inc 675,00013.6M $
8Immunovant Inc 545,62513.6M $
9JADE BIOSCIENCES INC 964,46213.6M $
10Contineum Therapeutics Inc 800,19810.5M $
11ZENAS BIOPHARMA INC 524,06610.2M $
12Neurogene Inc 500,00010.1M $
13Climb Bio Inc 1,334,1309.1M $
14Oruka Therapeutics Inc 183,3309M $
15Vera Therapeutics Inc 199,3488M $
16Evommune Inc 325,0007.5M $
17LB Pharmaceuticals Inc 300,0007.4M $
18Compass Therapeutics Inc 1,350,0007.1M $
19SCYNEXIS INC 7,554,3476.9M $
20Palisade Bio Inc 3,405,7576M $
21Context Therapeutics Inc 2,238,4965.9M $
22Relmada Therapeutics Inc 842,1065.9M $
23Silence Therapeutics PLC 1,020,4895.4M $
24Unicycive Therapeutics Inc 796,5585.2M $
25Tenax Therapeutics Inc 327,3075.2M $
26Cullinan Therapeutics Inc 300,0004.3M $
27Immix Biopharma Inc 350,0003.2M $
28Rezolute Inc 951,8092.9M $
29Humacyte Inc 3,750,0002.3M $
30AVALO THERAPEUTICS INC 124,6661.9M $
31Opus Genetics Inc 324,3401.5M $

Download this table: CSV, JSON

Sector breakdown

  • Unattributed 100.0 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • United States 98.3 %
  • United Kingdom 1.7 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1United States30313.2M $98.31 %
2United Kingdom15.4M $1.69 %
Cite this page

Titelia. "Holdings of GREAT POINT PARTNERS LLC". https://titelia.com/en/funds/US13F1281446